Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate added to bupivacaine paravertebral block for post-thoracotomy pain
ACTRN12625000580471Phase 4Not yet recruiting
- Sponsor
- University Hospital Center Sestre milosrdnice
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of magnesium sulfate and bupivacaine in postoperative pain (2 arms), sponsored by University Hospital Center Sestre milosrdnice. Primary endpoint: Time to first pain. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
magnesium sulfatebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12625000580471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625000580471.